Updates on the Treatment of Non-Small Cell Lung Cancer

In the past few years there have been major changes in the treatment lanscape inoncology;lung cancer is affected by those changes like almost no other solid tumors.the rise offurther second-and third-line tyrosin kinase inhibitors offers sequential therapy for patients withmutated non small cell lung cancer.Immunotherapy has found its way into clinical routine andpresents us with new challenges in managing side effects ,evaluating treatment response anddeciding on how long we teat our patients.The treatment algorithm of lung cancer has changed inthe last months and further practice-changing trials are coming up,so treating lung cancer patientsshows nowadays more challenging prespective with the possibility of subsequently appliedindividual therapies.I present 59-year-old man who had been diagnosed with stage IV lung squamous cellcarcinoma with brain metastasis admitted with respiratory distress and massive hemoptysis. He hada history of COPD and automated implantable cardiovertor/defibrillator. Chest radiography showedatelectasis of the left lower lobe and lingual.The aim of this presentation is discussion about variety of treatment modalities formanagement of massive hemoptysis in patients with bronchogenic carcinoma.